"PFIZERGEN" WILL BE PFIZER BIOTECH R&D COLLABORATION NETWORK for genetic and biotechnology research: Pfizer has entered agreements with Immusol, AEA Technology, Oxford Asymmetry and Myco Pharmaceuticals for joint R&D and for technologies and resources that will enhance internal Pfizer research operations, Pfizer announced March 24.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.
Marcus Vass and Vladimir Murovec of international law firm Osborne Clarke tell the Pink Sheet what the government's planned HDRS might mean for industry, and how it compares with the European Health Data Space.
The European Health Data Space framework will allow companies to accelerate R&D processes and identify new molecular targets faster by facilitating centralized access to certain types of high-quality data, Finland’s Orion Pharma says.
